MEDP(Medpace Holdings, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.14B | $1.46B | $1.89B | $2.11B | $2.53B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $198.62M | $278.70M | $336.82M | $446.87M | $534.93M |
| 净利润 | $181.85M | $245.37M | $282.81M | $404.39M | $451.12M |
| 经营现金流 | $263.33M | $388.05M | $433.37M | $608.82M | $713.22M |
| 自由现金流 | $235.06M | $351.17M | $396.73M | $572.27M | $681.87M |
| 摊薄每股收益 | $4.81 | $7.28 | $8.88 | $12.63 | $15.28 |